A Challenging Twist in Pulmonary Renal Syndrome

Case. We report a rare case of hydralazine-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. A 75-year-old African American woman with history of high blood pressure on hydralazine for 3 years presented with acute onset of shortness of breath and hemoptysis. Lab workup revealed a s...

Full description

Saved in:
Bibliographic Details
Main Authors: Rajaie Namas, Bernard Rubin, Wamidh Adwar, Alireza Meysami
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Case Reports in Rheumatology
Online Access:http://dx.doi.org/10.1155/2014/516362
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554067709132800
author Rajaie Namas
Bernard Rubin
Wamidh Adwar
Alireza Meysami
author_facet Rajaie Namas
Bernard Rubin
Wamidh Adwar
Alireza Meysami
author_sort Rajaie Namas
collection DOAJ
description Case. We report a rare case of hydralazine-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. A 75-year-old African American woman with history of high blood pressure on hydralazine for 3 years presented with acute onset of shortness of breath and hemoptysis. Lab workup revealed a severe normocytic anemia and a serum creatinine of 5.09 mg/dL (baseline 0.9). Bronchoscopy demonstrated active pulmonary hemorrhage. A urine sample revealed red cell casts and a renal biopsy demonstrated pauci-immune, focally necrotizing glomerulonephritis with small crescents consistent with possible anti-neutrophil cytoplasmic antibody-positive renal vasculitis. Serologies showed high-titer MPO-ANCA and high-titer anti-histone antibodies. She was treated with intravenous steroids and subsequently with immunosuppression after cessation of hydralazine. The patient was subsequently discharged from hospital after a rapid clinical improvement. Conclusion. Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis is a rare adverse effect and can present as a severe vasculitic syndrome with multiple organ involvement. Features of this association include the presence of high titer of anti-myeloperoxidase anti-neutrophil cytoplasmic antibody with multiantigenicity, positive anti-histone antibodies, and the lack of immunoglobulin and complement deposition. Prompt cessation of hydralazine may be sufficient to reverse disease activity but immunosuppression may be needed.
format Article
id doaj-art-208b16ac66124933a5f29ec6edf2c1bd
institution Kabale University
issn 2090-6889
2090-6897
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Case Reports in Rheumatology
spelling doaj-art-208b16ac66124933a5f29ec6edf2c1bd2025-02-03T05:52:20ZengWileyCase Reports in Rheumatology2090-68892090-68972014-01-01201410.1155/2014/516362516362A Challenging Twist in Pulmonary Renal SyndromeRajaie Namas0Bernard Rubin1Wamidh Adwar2Alireza Meysami3Department of Internal Medicine, Division of Rheumatology, Henry Ford Hospital, Wayne State University, Detroit, MI 48202, USADepartment of Internal Medicine, Division of Rheumatology, Henry Ford Hospital, Wayne State University, Detroit, MI 48202, USADepartment of Pathology, Henry Ford Hospital, Wayne State University, Detroit, MI 48202, USADepartment of Internal Medicine, Division of Rheumatology, Henry Ford Hospital, Wayne State University, Detroit, MI 48202, USACase. We report a rare case of hydralazine-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. A 75-year-old African American woman with history of high blood pressure on hydralazine for 3 years presented with acute onset of shortness of breath and hemoptysis. Lab workup revealed a severe normocytic anemia and a serum creatinine of 5.09 mg/dL (baseline 0.9). Bronchoscopy demonstrated active pulmonary hemorrhage. A urine sample revealed red cell casts and a renal biopsy demonstrated pauci-immune, focally necrotizing glomerulonephritis with small crescents consistent with possible anti-neutrophil cytoplasmic antibody-positive renal vasculitis. Serologies showed high-titer MPO-ANCA and high-titer anti-histone antibodies. She was treated with intravenous steroids and subsequently with immunosuppression after cessation of hydralazine. The patient was subsequently discharged from hospital after a rapid clinical improvement. Conclusion. Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis is a rare adverse effect and can present as a severe vasculitic syndrome with multiple organ involvement. Features of this association include the presence of high titer of anti-myeloperoxidase anti-neutrophil cytoplasmic antibody with multiantigenicity, positive anti-histone antibodies, and the lack of immunoglobulin and complement deposition. Prompt cessation of hydralazine may be sufficient to reverse disease activity but immunosuppression may be needed.http://dx.doi.org/10.1155/2014/516362
spellingShingle Rajaie Namas
Bernard Rubin
Wamidh Adwar
Alireza Meysami
A Challenging Twist in Pulmonary Renal Syndrome
Case Reports in Rheumatology
title A Challenging Twist in Pulmonary Renal Syndrome
title_full A Challenging Twist in Pulmonary Renal Syndrome
title_fullStr A Challenging Twist in Pulmonary Renal Syndrome
title_full_unstemmed A Challenging Twist in Pulmonary Renal Syndrome
title_short A Challenging Twist in Pulmonary Renal Syndrome
title_sort challenging twist in pulmonary renal syndrome
url http://dx.doi.org/10.1155/2014/516362
work_keys_str_mv AT rajaienamas achallengingtwistinpulmonaryrenalsyndrome
AT bernardrubin achallengingtwistinpulmonaryrenalsyndrome
AT wamidhadwar achallengingtwistinpulmonaryrenalsyndrome
AT alirezameysami achallengingtwistinpulmonaryrenalsyndrome
AT rajaienamas challengingtwistinpulmonaryrenalsyndrome
AT bernardrubin challengingtwistinpulmonaryrenalsyndrome
AT wamidhadwar challengingtwistinpulmonaryrenalsyndrome
AT alirezameysami challengingtwistinpulmonaryrenalsyndrome